157 related articles for article (PubMed ID: 28139499)
1. Desmoplasia influenced recurrence of disease and mortality in stage III colorectal cancer within five years after surgery and adjuvant therapy.
Zippi M; De Toma G; Minervini G; Cassieri C; Pica R; Colarusso D; Stock S; Crispino P
Saudi J Gastroenterol; 2017; 23(1):39-44. PubMed ID: 28139499
[TBL] [Abstract][Full Text] [Related]
2. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.
Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P
Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.
Yang L; Ma Q; Yu YY; Wang C; Meng WJ; Adell G; Albertsson M; Arbman G; Jarlsfelt I; Peng ZH; Li Y; Zhou ZG; Sun XF
Medicine (Baltimore); 2014 Dec; 93(28):e266. PubMed ID: 25526455
[TBL] [Abstract][Full Text] [Related]
4. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.
Ueno H; Shinto E; Shimazaki H; Kajiwara Y; Sueyama T; Yamamoto J; Hase K
Ann Surg Oncol; 2015 May; 22(5):1504-12. PubMed ID: 25395146
[TBL] [Abstract][Full Text] [Related]
5. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
[TBL] [Abstract][Full Text] [Related]
6. Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy.
Mejri N; Dridi M; Labidi S; El Benna H; Daoud N; Boussen H
Clin Transl Oncol; 2017 Dec; 19(12):1524-1530. PubMed ID: 28589428
[TBL] [Abstract][Full Text] [Related]
7. Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?
Ozturk MA; Dane F; Karagoz S; Tural D; Selcukbiricik F; Demirelli F; Buyukunal E; Ozguroglu M; Turna H; Erdamar S; Celikel CA; Bozkurtlar EB; Yumuk PF; Mandel NM; Turhal NS; Serdengecti S
Hepatogastroenterology; 2015; 62(137):59-64. PubMed ID: 25911868
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Kajiwara Y; Okamoto K; Mochizuki S; Tsujimoto H; Shinto E
Am J Surg Pathol; 2019 Aug; 43(8):1015-1022. PubMed ID: 31094924
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting.
Chapuis PH; Bokey EL; Clarke S; Beale P; Dent OF
ANZ J Surg; 2009 Oct; 79(10):685-92. PubMed ID: 19878161
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
11. Effect of Adjuvant Chemotherapy on Survival of Elderly Patients With Stage III Colorectal Cancer.
Shibutani M; Maeda K; Kashiwagi S; Hirakawa K; Ohira M
Anticancer Res; 2021 Jul; 41(7):3615-3624. PubMed ID: 34230158
[TBL] [Abstract][Full Text] [Related]
12. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
15. [Principles of oncologic drug therapy following surgery for bowel cancer].
Ristamäki R; Ålgars A
Duodecim; 2016; 132(12):1155-9. PubMed ID: 27483631
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in colorectal cancer.
Papadopoulou-Zekeridou P; Alexandridis E; Delithanasis I; Zekeridis T; Lagra F; Krokidis X; Lazaridis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s149-51. PubMed ID: 15655604
[TBL] [Abstract][Full Text] [Related]
17. Tumor Diameter is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer.
Maeda C; Hidaka E; Mori Y; Mukai S; Miyachi H; Sawada N; Ishida F; Kudo SE
Dig Surg; 2015; 32(5):338-43. PubMed ID: 26183549
[TBL] [Abstract][Full Text] [Related]
18. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
19. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
20. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]